Delivery Order SPE2DB22D1017-SPE2DB25FF0AT
Award Date
11/26/24
Potential Completion Date
11/27/24
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,850.06, is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,525.20, is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,899.19, is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 1, 2025. This contract award is not designated as a set-aside. AmerisourceBergen Drug Corp is the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,143.87 and is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. The contract is a firm fixed-price delivery order and has an ultimate completion date of April 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,746.97, is a delivery order for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,694.49, is a delivery order for ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical supplies. It is a firm fixed-price contract with a completion date of January 24, 2025. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,839.13, is a delivery order for ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a period of performance through February 10, 2025 and uses a firm fixed price pricing type. This award is not associated with a set-aside program. AmerisourceBergen has an Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,619.04, is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. The contract has an ultimate completion date of February 13, 2025 and is a Firm Fixed Price Delivery Order. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,387.45, is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. The contract has an ultimate completion date of November 19, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,594.58, is for the delivery of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This contract is a Delivery Order type with a Firm Fixed Price pricing mechanism. The ultimate completion date for this award is February 6, 2025. The contract is not designated as a set-aside....